Particularly in CLL, MALAT1 could serve as a clinical biomarker that seems to be a surrogate indicator of the degree of stimuli the CLL cells receive from the microenvironment. The gene discussed is MALAT1; the disease is B-cell chronic lymphocytic leukemia.